BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38658981)

  • 1. OTUD5 promotes the growth of hepatocellular carcinoma by deubiquitinating and stabilizing SLC38A1.
    Yang Y; Jia S; Zhu N; Xiao X; Ma Y; Tu K; Guo Y; Xu Q
    Biol Direct; 2024 Apr; 19(1):31. PubMed ID: 38658981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deubiquitinating enzyme USP46 suppresses the progression of hepatocellular carcinoma by stabilizing MST1.
    Qiu Y; Huang D; Sheng Y; Huang J; Li N; Zhang S; Hong Z; Yin X; Yan J
    Exp Cell Res; 2021 Aug; 405(1):112646. PubMed ID: 34029571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deubiquitinase OTUD5 is a positive regulator of mTORC1 and mTORC2 signaling pathways.
    Cho JH; Kim K; Kim SA; Park S; Park BO; Kim JH; Kim SY; Kwon MJ; Han MH; Lee SB; Park BC; Park SG; Kim JH; Kim S
    Cell Death Differ; 2021 Mar; 28(3):900-914. PubMed ID: 33110214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Deubiquitinase Ovarian Tumor Domain-Containing Protein 5 (OTUD5) on Radiosensitivity of Cervical Cancer by Regulating the Ubiquitination of Akt and its Mechanism.
    Yin F; He H; Zhang B; Zheng J; Wang M; Zhang M; Cui H
    Med Sci Monit; 2019 May; 25():3469-3475. PubMed ID: 31075090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. USP40 promotes hepatocellular carcinoma cell proliferation, migration and stemness by deubiquitinating and stabilizing Claudin1.
    Wu Q; Qiu Y; Guo J; Yuan Z; Yang Y; Zhu Q; Zhang Z; Guo J; Wu Y; Zhang J; Huang D; Tu K; Hu X
    Biol Direct; 2024 Feb; 19(1):13. PubMed ID: 38308285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The deubiquitinating enzyme USP19 facilitates hepatocellular carcinoma progression through stabilizing YAP.
    Tian Z; Xu C; He W; Lin Z; Zhang W; Tao K; Ding R; Zhang X; Dou K
    Cancer Lett; 2023 Nov; 577():216439. PubMed ID: 37832781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-301b-3p contributes to tumour growth of human hepatocellular carcinoma by repressing vestigial like family member 4.
    Guo Y; Yao B; Zhu Q; Xiao Z; Hu L; Liu X; Li L; Wang J; Xu Q; Yang L; Huang D
    J Cell Mol Med; 2019 Aug; 23(8):5037-5047. PubMed ID: 31207037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deubiquitinating enzyme Josephin-2 stabilizes PHGDH to promote a cancer stem cell phenotype in hepatocellular carcinoma.
    Wang Y; Li ZX; Wang JG; Li LH; Shen WL; Dang XW
    Genes Genomics; 2023 Feb; 45(2):215-224. PubMed ID: 36583817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA 01559 mediates the malignant phenotypes of hepatocellular carcinoma cells through targeting miR-511.
    Su Q; Wang H
    Clin Res Hepatol Gastroenterol; 2021 Mar; 45(2):101648. PubMed ID: 33588099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The deubiquitinase OTUD3 stabilizes ACTN4 to drive growth and metastasis of hepatocellular carcinoma.
    Xie P; Chen Y; Zhang H; Zhou G; Chao Q; Wang J; Liu Y; Fang J; Xie J; Zhen J; Wang Z; Hao L; Huang D
    Aging (Albany NY); 2021 Aug; 13(15):19317-19338. PubMed ID: 34380780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UBE2O promotes hepatocellular carcinoma cell proliferation and invasion by regulating the AMPKα2/mTOR pathway.
    Shi Z; Liu R; Lu Q; Zeng Z; Liu Y; Zhao J; Liu X; Li L; Huang H; Yao Y; Huang D; Xu Q
    Int J Med Sci; 2021; 18(16):3749-3758. PubMed ID: 34790050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubiquitination of UVRAG by SMURF1 promotes autophagosome maturation and inhibits hepatocellular carcinoma growth.
    Feng X; Jia Y; Zhang Y; Ma F; Zhu Y; Hong X; Zhou Q; He R; Zhang H; Jin J; Piao D; Huang H; Li Q; Qiu X; Zhang Z
    Autophagy; 2019 Jul; 15(7):1130-1149. PubMed ID: 30686098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ubiquitin-specific protease 2a promotes hepatocellular carcinoma progression via deubiquitination and stabilization of RAB1A.
    Xiong B; Huang J; Liu Y; Zou M; Zhao Z; Gong J; Wu X; Qiu C
    Cell Oncol (Dordr); 2021 Apr; 44(2):329-343. PubMed ID: 33074477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of OTUD5 in non-small cell lung cancer cell proliferation, invasion, and migration.
    Li X; Lu B; Zhang L; Yang J; Cheng Y; Yan D
    Bosn J Basic Med Sci; 2022 Oct; 22(6):901-911. PubMed ID: 35765958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deubiquitinating enzyme JOSD2 promotes hepatocellular carcinoma progression through interacting with and inhibiting CTNNB1 degradation.
    Huang Y; Zeng J; Liu T; Xu Q; Song X; Zeng J
    Cell Biol Int; 2022 Jul; 46(7):1089-1097. PubMed ID: 35568970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocyte Deubiquitinating Enzyme OTUD5 Deficiency is a Key Aggravator for Metabolic Dysfunction-Associated Steatohepatitis by Disturbing Mitochondrial Homeostasis.
    Dai J; Zhang L; Zhang R; Ge J; Yao F; Zhou S; Xu J; Yu K; Xu J; Jiang L; Jin K; Dai X; Li J; Li Q
    Cell Mol Gastroenterol Hepatol; 2024; 17(3):399-421. PubMed ID: 38036082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRIM52 up-regulation in hepatocellular carcinoma cells promotes proliferation, migration and invasion through the ubiquitination of PPM1A.
    Zhang Y; Tao R; Wu SS; Xu CC; Wang JL; Chen J; Yu YS; Tang ZH; Chen XH; Zang GQ
    J Exp Clin Cancer Res; 2018 Jun; 37(1):116. PubMed ID: 29898761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deubiquitinase PSMD14 enhances hepatocellular carcinoma growth and metastasis by stabilizing GRB2.
    Lv J; Zhang S; Wu H; Lu J; Lu Y; Wang F; Zhao W; Zhan P; Lu J; Fang Q; Xie C; Yin Z
    Cancer Lett; 2020 Jan; 469():22-34. PubMed ID: 31634528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OTU deubiquitinase 5 inhibits the progression of non-small cell lung cancer via regulating p53 and PDCD5.
    Kang XY; Zhang J; Tang L; Huang L; Tong J; Fu Q
    Chem Biol Drug Des; 2020 Aug; 96(2):790-800. PubMed ID: 32248621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NT5DC2 promotes tumor cell proliferation by stabilizing EGFR in hepatocellular carcinoma.
    Li KS; Zhu XD; Liu HD; Zhang SZ; Li XL; Xiao N; Liu XF; Xu B; Lei M; Zhang YY; Shi WK; Cao MQ; Xu YF; Tang ZY; Sun HC
    Cell Death Dis; 2020 May; 11(5):335. PubMed ID: 32382041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.